VISTAS 2023 - Drive the Momentum - October 18-20, Caesars Palace, Las Vegas - Learn More

Dr. Byte: Insights into What’s Next in Digital Therapeutics

Do you know why Digital Health and Digital Therapeutics (DTx) is gaining the interest of medical device and pharma companies? DTx is a rapidly emerging field that combines advanced digital technologies with clinical evidence to provide personalized and effective treatments to patients.

In this 30-minute educational session, you’ll learn more about this exciting field.

  • Explore the challenges DTx companies face during payer negotiations and how this can impact pricing models due to traditional reimbursement schemes that do not fit into the DTx reimbursement model.
  • Analyze and discuss the obstacles that DTx manufacturers face in Europe due to the lack of Europe-wide regulation for these therapies.
  • Explore the German procedure that is considered a pioneer in the regulation of DTx and its potential impact on the broader European market.


Alejandra Garitonandia

Alejandra Garitonandia

Industry Principal of Life Sciences at Vistex EMEA